Intestinal Short-Chain Fatty Acids in Patients with Bronchial Asthma
https://doi.org/10.22416/1382-4376-2019-29-2-53-59
Abstract
Aim. Tostudy the content and profile of short-chain fatty acids (SCFAs) in faeces of patients with bronchial asthma and healthy individuals, as well as to evaluate possible correlations between the SCFA spectrum and clinical phenotype of patients with bronchial asthma.
Materials and methods. 44 patients with asthma and 17 healthy volunteers participated in the study. All participants underwent a generally accepted range of clinical and laboratory studies, as well as functional respiratory tests. The SCFA spectrum was determined using gas-liquid chromatographic analysis. The results of patients with asthma showed a significant decrease in the total fatty acid content in faeces (p <0.001); changes in the absolute concentrations of individual acids, such as acetate (p <0.001), propionate (p <0.001) and butyrate (p <0.001); as well as a change in the total isoacid content (p <0.001). In 83% of the cases, the anaerobic type of the SCFA spectrum was detected. The aerobic type of the SCFA metabolic profile was detected in 17% of the cases. The change in the metabolic profile did not depend on the phenotype of the disease.
Conclusion. Changes in SCFAs indicate pronounced disorders in the microbiocenosis of the intestinal biotope. The values of the anaerobic index in the context of various changes in the acid metabolic profile indicate the disturbance of the microorganism’s habitat, contributing to the growth of anaerobic or aerobic microflora populations.
About the Authors
O. Yu. ZolnikovaRussian Federation
Cand. Sci. (Med.), Associate Professor, Department of Propaedeutics of Internal Diseases, Medical Faculty
N. D. Potskhverashvili
Russian Federation
Doctor, Pulmonology Department, V.H. Vasilenko Clinic of Internal Diseases Propaedeutics, Gastroenterology and Hepatology
N. I. Kokina
Russian Federation
Cand. Sci. (Med.), Associate Professor, Department of Propaedeutics of Internal Diseases, Medical Faculty; Departmental Head, Pulmonology Department, V.H. Vasilenko Clinic of Internal Diseases, Propedeutics, Gastroenterology and Hepatology
A. S. Trukhmanov
Russian Federation
Dr. Sci. (Med.), Prof., Department of Propaedeutics of Internal Diseases, Medical Faculty
V. T. Ivashkin
Russian Federation
Dr. Sci. (Med.), RAS Academician, Prof., Departmental Head, Department of Propaedeutics of Internal Diseases, Medical Faculty; Director, V.H. Vasilenko Clinic of Internal Diseases, Propedeutics, Gastroenterology and Hepatology
References
1. Cummings J.A. Short chain fatty acids in the human colon. Gut. 1981;22(9):763–79.
2. Cerdá B., Pérez M., Pérez-Santiago J. Gut Microbiota Modification: Another Piece in the Puzzle of the Benefits of Physical Exercise in Health? Front. Physiol. 2016;7:51.
3. Ganapathy V., Thangaraju M., Singh N. Transporters and receptors for short-chain fatty acids as the molecular link between colonic bacteria and the host. Curr. Opin. Pharmacol. 2013;13:869–74.
4. Berthon B., Macdonald-Wicks L., Gibson P., Wood L. Investigation of the association between dietary intake, disease severity and airway inflammation in asthma. Respirology. 2013;18:447–54.
5. Trompette A., Gollwitzer E. et al. Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis. Nature Medicine. 2014;20;159–66.
6. Gallaracher D.J, Kotecha S. Respiratory Microbiome of New-Born Infants Front Pediatr. 2016;4:10.
7. Venkataraman A., Bassis Ch., Beck J., Young V. Application of a Neutral Community Model to Assess Structuring of the Human Lung Microbiome. mBio. 2015;6;e02284-14.
8. Arrieta M. Early infancy microbial and metabolic alterations affect risk of childhood asthma. Sci. Transl. Med. 2015;7:307–12.
9. Sun M., Wu W., Liu Z. Microbiota metabolite short chain fatty acids, GPCR, and inflammatory bowel diseases. J Gastroenterol. 2017;52:1–8.
10. Siavoshian S. Butyrate and trichostatin A effects on the proliferation. differentiation of humen intestinal epithelial cells: induction of cyclin D3 and p21 expression. Gut. 2000;46:507–14.
11. Louis P., Young P., Holtrop G., Flint H.J. Diversity of human colonic butyrateproducing bacteria revealed by analysis of the butyryl-CoA: acetate CoA-transferase gene. Environ Microbiol. 2010;12(2):304–14.
12. Potskhverashvili N.D., Zolnikova О.Yu., Kokina N.I., Dzhakhaya N.L., Sedova A.V., Bueverova E.L., Trukhmanov A.S. Small Bowel Bacterial Overgrowth Syndrome in Patients with Bronchial Asthma. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2018;28(4):47–54. DOI: 10.22416/1382-4376-2018-28-4-47-54
13. Ivashkin V., Zolnikova O., Potskherashvili N., Trukhmanov A., Kokina N., Dzhakhaya N. A correction of a gut microflora composition for the allergic bronchial asthma complex therapy. Italian Journal of Medicine. 2018;12:260–4. DOI: 10.4081/itjm.2018.1040
Review
For citations:
Zolnikova O.Yu., Potskhverashvili N.D., Kokina N.I., Trukhmanov A.S., Ivashkin V.T. Intestinal Short-Chain Fatty Acids in Patients with Bronchial Asthma. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2019;29(2):53-59. (In Russ.) https://doi.org/10.22416/1382-4376-2019-29-2-53-59